Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
10.86 -0.30 (-2.69%)
Nov 29, 2021 4:00 PM EST - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 389.52 | 428.41 | 346.64 | 298.28 | 273.96 | 149.56 | 76.44 | 22.88 | 150.25 | 65.87 |
| Revenue Growth | -9.08% | 23.59% | 16.21% | 8.88% | 83.18% | 95.66% | 234.06% | -84.77% | 128.09% | - |
| Cost of Revenue | 3.14 | 20.35 | 33 | 19.41 | 2.24 | 17.65 | 25.58 | 7.2 | 0.97 | 0 |
| Gross Profit | 386.39 | 408.07 | 313.64 | 278.87 | 271.72 | 131.91 | 50.85 | 15.68 | 149.28 | 65.87 |
| Selling, General & Admin | 140 | 172.45 | 219.68 | 231.18 | 173.28 | 125.25 | 118.33 | 123.23 | 92.54 | 45.92 |
| Research & Development | 88.06 | 115.04 | 101.06 | 88.15 | 139.49 | 108.75 | 101.89 | 102.38 | 113.47 | 86.09 |
| Other Operating Expenses | 15.38 | 0.45 | 174.62 | 6.21 | 0.98 | 0 | 0 | 42.07 | 16.03 | 0 |
| Operating Expenses | 243.45 | 287.95 | 495.36 | 325.54 | 313.75 | 233.99 | 220.22 | 267.68 | 222.04 | 132.01 |
| Operating Income | 142.94 | 120.12 | -181.72 | -46.67 | -42.04 | -102.09 | -169.37 | -252 | -72.76 | -66.14 |
| Interest Expense / Income | 29.48 | 36.6 | 37.72 | 36.37 | 39.15 | 31.1 | 21.17 | 21 | 0.06 | 0.06 |
| Other Expense / Income | 4.6 | 62.02 | 62.93 | 33.89 | 0.52 | 9.49 | -0.92 | -0.19 | -0.2 | -1.36 |
| Pretax Income | 108.86 | 21.51 | -282.37 | -116.94 | -81.71 | -142.67 | -189.62 | -272.81 | -72.62 | -64.85 |
| Income Tax | 2.69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 106.18 | 21.51 | -282.37 | -116.94 | -81.71 | -142.67 | -189.62 | -272.81 | -72.62 | -64.85 |
| Net Income Common | 106.18 | 21.51 | -282.37 | -116.94 | -81.71 | -142.67 | -189.62 | -272.81 | -72.62 | -64.85 |
| Net Income Growth | 393.73% | - | - | - | - | - | - | - | - | - |
| Shares Outstanding (Basic) | 159 | 156 | 153 | 149 | 145 | 142 | 137 | 116 | 106 | 100 |
| Shares Outstanding (Diluted) | 161 | 156 | 153 | 149 | 145 | 142 | 137 | 116 | 106 | 100 |
| Shares Change | 2.97% | 2.22% | 2.44% | 2.80% | 1.95% | 3.91% | 18.09% | 8.88% | 6.54% | - |
| EPS (Basic) | 0.67 | 0.14 | -1.85 | -0.78 | -0.56 | -1.00 | -1.39 | -2.35 | -0.68 | -0.65 |
| EPS (Diluted) | 0.66 | 0.14 | -1.85 | -0.78 | -0.56 | -1.00 | -1.39 | -2.35 | -0.68 | -0.65 |
| EPS Growth | 371.43% | - | - | - | - | - | - | - | - | - |
| Free Cash Flow Per Share | 1.05 | 0.02 | -0.46 | -0.69 | -0.21 | -0.78 | -1.16 | -2.44 | -0.79 | -0.85 |
| Gross Margin | 99.19% | 95.25% | 90.48% | 93.49% | 99.18% | 88.20% | 66.53% | 68.52% | 99.36% | 100.00% |
| Operating Margin | 36.70% | 28.04% | -52.42% | -15.65% | -15.35% | -68.26% | -221.58% | -1101.36% | -48.43% | -100.41% |
| Profit Margin | 27.26% | 5.02% | -81.46% | -39.20% | -29.83% | -95.40% | -248.07% | -1192.31% | -48.34% | -98.45% |
| Free Cash Flow Margin | 42.87% | 0.89% | -20.10% | -34.67% | -10.92% | -74.11% | -208.16% | -1236.60% | -55.64% | -128.91% |
| Effective Tax Rate | 2.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% |
| EBITDA | 141.9 | 63.69 | -232.67 | -67.91 | -31.3 | -99.94 | -156.12 | -240.08 | -61.24 | -54.79 |
| EBITDA Margin | 36.43% | 14.87% | -67.12% | -22.77% | -11.42% | -66.83% | -204.25% | -1049.26% | -40.76% | -83.17% |
| EBIT | 138.34 | 58.11 | -244.64 | -80.57 | -42.56 | -111.57 | -168.45 | -251.81 | -72.57 | -64.79 |
| EBIT Margin | 35.51% | 13.56% | -70.58% | -27.01% | -15.53% | -74.60% | -220.38% | -1100.52% | -48.30% | -98.35% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).